Regulation of glucocorticoid receptor mRNA in nasal mucosa by local administration of fluticasone and budesonide

Journal of Allergy and Clinical Immunology

Volumn 97, Issue 2, 1996, Pages 655-661

  Knutsson, Per Urban ^a   Brönnegård, Mikael ^a   Marcus, Claude ^a   Stierna, Pontus ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

allergic rhinitis; budesonide; fluticasone propionate; Glucocorticoid receptor; mRNA; topical corticosteroids

Indexed keywords

BUDESONIDE; FLUTICASONE PROPIONATE; GLUCOCORTICOID RECEPTOR;

ALLERGIC RHINITIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MESSENGER RNA SYNTHESIS; NORMAL HUMAN; NOSE MUCOSA; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION;

EID: 0030048554     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(96)70311-1     Document Type: Article

References (28)

1. Bryson HM, Faulds D. Intranasal fluticasone propionate: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in allergic rhinitis. Drugs 1992;43:760-75.
2. Brogden RN, McTavish D. Budesonide: an updated review of its pharmacological properties, and therapeutic efficacy in asthma and rhinitis. Drugs 1992;44:375-407.
3. Pipkorn U. Glucocorticoids in nasal therapy. In: Schleimer RP, Claman HN, Oronsky A eds. Antiinflammatory steroid action: basic and clinical aspects. San Diego: Academic Press, Inc., 1989:469-93.
4. Svec F. Minireview: glucocorticoid receptor regulation. Life Sci 1985;36:2359-66.
5. Burnstein KL, Cidlowski JA. At the cutting edge: the down side of glucocorticoid receptor regulation. Mol Cell Endocrinol 1992;83:C1-8.
6. Goulding NJ, Guyre PM. Regulation of inflammation by lipocortin 1. Immunol Today 1992; 13:295-7.
7. Okret S, Dong Y, Brönnegård M, Gustafsson JÅ. Regulation of glucocorticoid receptor expression. Biochimie 1991; 73:51-9.
8. Burnstein KL, Bellingham DL, Jewell CM, Powell-Oliver FE, Cidlowski JA. Autoregulation of glucocorticoid receptor gene expression. Steroids 1991;56:52-8.
9. Dong Y, Poellinger L, Gustavsson J-Å, Okret S. Regulation of glucocorticoid receptor expression: evidence for transcriptional and posttranscriptional mechanisms. Mol Endocrinol 1988;2:1256-64.
10. McIntyre WR, Samuels HH. Triamcinolone acetonide regulates glucocorticoid-receptor levels by decreasing the half-life of the activated nuclear-receptor form. J Biol Chem 1985;260:418-27.
11. Karin M, Richards R. Human metallothionein genes -primary structure of the metallothionein II gene and a related processed gene. Nature 1982;299:797-802.
12. Loe N, Haslinge A, Karin M, Tjian R. Activation of transcription by two factors that bind promoter and enhances sequences of the human metallothionein gene and SV40. Nature 1987;325:368-72.
13. Karin M. Metallothioneins: proteins in search of function. Cell 1985;41:9-10.
14. Kägi JHR. Overview of metallothionein. In: Riordan JF, Vallee BL, eds. Methods in enzymology. San Diego: Academic Press, Inc., 1991;205:613-26.
15. Brönnegård M, Werner S, Gustafsson J-Å. Regulation of glucocorticoid receptor expression in cultured fibroblasts from a patient with familial glucocorticoid resistance. J Steroid Biochem Mol Biol 1991;39:693-701.
16. Brattsand R, Axelsson BI. New inhaled glucocorticosteroids. In: Barnes PJ, ed. New drugs for asthma. London: IBC Technical Services Ltd, 1992;2:193-208.
17. Pipkorn U, Karlsson G. Methods for obtaining specimens from the nasal mucosa for morphological and biochemical analysis. Eur Respir J 1988;1:856-62.
18. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
19. Hollenberg SM, Weinberger C, Ong ES, et al. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 1985;318:635-41.
20. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977;74:5463-7.
21. Durham DM, Palmiter RP. A practical approach for quantitating specific mRNA by solution hybridization. Anal Biochem 1983;131:385-93.
22. Brönnegård M, Andersson O, Edwall D, Lund J, Norstedt G, Carlstedt-Duke J. Human calpactin II (lipocortin I): messenger ribonucleic acid is not induced by glucocorticoids. Mol Endocrinol 1988;2:732-9.
23. Knutsson PU, Stierna P, Claude M, Carlstedt-Duke J, Carlström K, Brönnegård M. Effects of intranasal glucocorticoids on endogenous glucocorticoid peripheral and central function. Endocrinology 1995;144:301-10.
24. Halama AR, Decreton S, Bijloos JM, Clement PAR. Density of epithelial cells in the normal human nose and the paranasal sinus mucosa. A scanning electron microscopic study. Rhinology 1990;28:25-32.
25. Pipkorn U, Berge T. Long-term treatment with budesonide in vasomotor rhinitis. Acta Otolaryngol 1983;95: 167-71.
26. Lindqvist N, Balle VH, Karma P, et al. Long-term safety and efficacy of budesonide nasal aerosol in perennial rhinitis. J Allergy 1986;41:179-86.
27. Bende M, Mark J. Long-term effects of topical corticosteroids in the nose. J Laryngol Otol 1992;106:810-2.
28. Loe N, Haslinge A, Karin M, Tjian R. Activation of transcription by two factors that bind promotor and enhancer sequences of the human metallothionein gene and SV40. Nature 1987;325:368-72.